Urological cancer. The benefits of intermittent androgen-deprivation therapy. [electronic resource]
- Nature reviews. Clinical oncology Dec 2012
- 672-3 p. digital
Publication Type: Journal Article; Comment
1759-4782
10.1038/nrclinonc.2012.201 doi
Androgen Antagonists--administration & dosage Humans Male Prostatic Neoplasms--drug therapy